A 36-year-old man presented to the hospital with a 2-day history of fever, sore throat, and fatigue 5 days after visiting Wuhan, China. His temperature on admission was 37.8°C (100.04°F). Pulmonary auscultation was normal. Laboratory studies showed a normal white blood cell count (4.6 × 10 9 /L) with a differential count of 53.1% neutrophils. The blood procalcitonin level was normal. Chest CT showed multiple peripheral ground-glass opacities in both lungs with more involvement of the left upper lobe, lingular segment (Figure a-c). At admission, the real-time fluorescence polymerase chain reaction (RT-PCR) assay of the sputum was negative for the 2019 novel coronavirus (2019-nCoV) nucleic acid.Repeat CT chest performed 3 days after admission showed transformation of ground-glass opacities to more consolidation (Figure d-f ). A repeat RT-PCR 2019-nCoV Images in a 36-year-old man with a 2-day history of fever, sore throat, and fatigue 5 days after visiting Wuhan, China, and a negative sputum real-time fluorescence polymerase chain reaction assay for the 2019 novel coronavirus. (a, b) Chest CT scans obtained at presentation show ground-glass opacities (red box) in the right upper lobe and the lingular segment and left lower lobe (b). (c) Volume rendering of chest CT scan obtained at admission. (d, e) CT scans obtained 3 days after admission show progression of ground-glass opacities to an atoll sign in the right upper lobe (red boxes in d) and left lower lobe consolidation (red boxes in e). (f) Volume rendering of chest CT scan obtained 3 days after admission shows the new areas of consolidation. See also Movies 1 and 2 (online)This copy is for personal use only. To order printed copies, contact reprints@rsna.org

Highly active and stable bifunctional electrocatalysts for overall water splitting are important for clean and renewable energy technologies. The development of energy-saving electrocatalysts for hydrogen evolution reaction (HER) by replacing the sluggish oxygen evolution reaction (OER) with a thermodynamically favorable electrochemical oxidation (ECO) reaction has attracted increasing attention. In this study, a self-supported, hierarchical, porous, nitrogen-doped carbon (NC)@CuCo 2 N x /carbon fiber (CF) is fabricated and used as an efficient bifunctional electrocatalyst for both HER and OER in alkaline solutions with excellent activity and stability. Moreover, a two-electrode electrolyzer is assembled using the NC@CuCo 2 N x /CF as an electrocatalyst at both cathode and anode electrodes for H 2 production and selective ECO of benzyl alcohol with high conversion and selectivity. The excellent electrocatalytic activity is proposed to be mainly due to the hierarchical architecture beneficial for exposing more catalytic active sites, enhancing mass transport. Density functional theoretical calculations reveal that the adsorption energies of key species can be modulated due to the synergistic effect between CoN and CuN. This work provides a reference for the development of high-performance bifunctional electrocatalysts for simultaneous production of H 2 and high-value-added fine chemicals.

Epithelial-mesenchymal transition (EMT) has been recognized as a key element of cell migration, invasion, and drug resistance in several types of cancer. In this study, our aim was to clarify microRNAs (miRNAs)-related mechanisms underlying EMT followed by acquired resistance to chemotherapy in glioblastoma (GBM). We used multiple methods to achieve our goal including microarray analysis, qRT-PCR, western blotting analysis, loss/gain-of-function analysis, luciferase assays, drug sensitivity assays, wound-healing assay and invasion assay. We found that miR-203 expression was significantly lower in imatinib-resistant GBM cells (U251AR, U87AR) that underwent EMT than in their parental cells (U251, U87). Ectopic expression of miR-203 with miRNA mimics effectively reversed EMT in U251AR and U87AR cells, and sensitized them to chemotherapy, whereas inhibition of miR-203 in the sensitive lines with antisense oligonucleotides induced EMT and conferred chemoresistance. SNAI2 was identified as a direct target gene of miR-203. The knockdown of SNAI2 by short hairpin RNA (shRNA) inhibited EMT and drug resistance. In GBM patients, miR-203 expression was inversely related to SNAI2 expression, and those tumors with low expression of miR-203 experienced poorer clinical outcomes. Our findings indicate that re-expression of miR-203 or targeting SNAI2 might serve as potential therapeutic approaches to overcome chemotherapy resistance in GBM.

No abstract